Systemic lupus erythematosus (SLE) can present at any age and is associated with immunemediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this and more with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:

Systemic Lupus Erythematosus
https://jamanetwork.com/journals/jama...

Podcast was originally published on April 8, 2024.
https://edhub.amaassn.org/jnlearnin...


Follow JAMA Clinical Reviews on:

Youtube:    • JAMA Clinical Reviews  
Apple Podcasts: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/229VuDi...
Pocket Casts: https://pca.st/3ghw
Your podcast app of choice: https://pod.link/1027430378
Website: https://jamanetwork.com/journals/jama...


For more from JAMA
• https://www.jama.com
•   / jamajournal  
•   / jama_current  
•   / jamanetwork  

Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
•   / jamanetwork  
•   / jamanetwork  
•   / jamanetwork  
•   / jamanetwork